Skip to content

Virtual reality for pain management during transcatheter arterial chemoembolization: a randomized control trial

Virtual reality for pain management during transcatheter arterial chemoembolization: a randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074343
Enrollment
Unknown
Registered
2023-08-04
Start date
2023-08-06
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

experimental group:On the basis of routine nursing, the experimental group will apply 3D virtual reality technology to implement intraoperative intervention.
control group:The control group will be given routine care during the operation

Sponsors

Zhongda Hospital, Affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: If any of the following is "no", this subject cannot participate in the trial: ? patients diagnosed by a clinician as needing transcatheter hepatic arterial chemoembolization; 2 Clear consciousness, no communication, cognitive, audio-visual impairment; ? NRS score =3 for the last 2 times of pain; ? Voluntarily participate in and sign informed consent in person; Age 18-80 years old, gender is not limited.

Exclusion criteria

Exclusion criteria: Exclusion criteria: If any of the following is "Yes", the subject cannot participate in the experiment: ? The person who cannot wear the VR device; ? Patients who are prone to vertigo using virtual reality technology; ? People with mental illness or a history of substance abuse; Patients with epilepsy or a history of seizures; ? patients with photophobia and diabetic retinopathy; ? People with high blood pressure, heart disease, and serious dysfunction of vital organs; (7) Serious dysfunction of vital organs or serious complications; ? Patients with infectious diseases; ? The researchers judged that they were not suitable for the study.

Design outcomes

Primary

MeasureTime frame
numerical rating scale(NRS);

Secondary

MeasureTime frame
self-rating anxiety scale;Intraoperative analgesic use (time, dose, cause and frequency);Rate of uninterrupted completion of surgery without complaint of pain ;degree of satisfaction;

Countries

China

Contacts

Public ContactXue Youhua

Zhongda Hospital, Affiliated to Southeast University

xueyouhua3098@163.com+86 138 5176 5776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026